BCL2 and hematologic disorder: All of these hematological malignancies are characterized by their own genetic hallmarks, even though most of them display deregulation of the B-cell receptors (BCR), NFkB, Notch (see articles associated to this Frontiers topic) or BCL2-family networks, leading to increased survival and enhanced chemoresistance.